Gastrointestinal manifestions in patients with cystic fibrosis

Authors
Citation
Mj. Lentze, Gastrointestinal manifestions in patients with cystic fibrosis, MONATS KIND, 149(3), 2001, pp. 239
Citations number
33
Categorie Soggetti
Pediatrics
Journal title
MONATSSCHRIFT KINDERHEILKUNDE
ISSN journal
00269298 → ACNP
Volume
149
Issue
3
Year of publication
2001
Database
ISI
SICI code
0026-9298(200103)149:3<239:GMIPWC>2.0.ZU;2-5
Abstract
The gene product of cystic fibrosis - the CFTR - is expressed within the ga strointestinal tract in epithelial cells of the small and large bowel, the pancreatic acini and the biliary tree, but not in the liver. For same of th e manifestations of CF in the GI-tract there is a genotype-phenotype-correl ation. Patients with the Delta F508 mutation present with pancreatic insuff iciency (PI). PI correlates with the appearance of meconium ileus and dista l intestinal obstruction syndrome (DIOS). The gold standard for the diagnos is of PI is the quantitative determination of fat in a 3-5 stool collection . The treatment consists in the administration of microcapsulated pancreati c extracts in a dose of 5.000 to 10.0000 units of lipase/kg/day. Higher dos es up to 50.000 units of lipase/kg/day have been implicated with the occure nce of fibrosing colonopathy in the early 90ties. As for the hepato-biliary manifestations of CF, cholelithiasis, atresia of the cystic duct and a bil iary cirrhosis are the main pathologies. The focal nodular cirrhosis turns into a multilobular cirrhosis in 24% of all adults with CF combined with po rtal hypertension and esophageal varices. In newborn a prolonged neonatal c holestasis can occur with symptoms similar to those in extrahepatic biliary atresia. The treatment of the hepatopathy in CF is difficult. The oral adm inistration of ursodeoxcholic acid (15-20 mg/kg/day) was shown to be effect ive in some studies. Up to 25% of CF patients are suffering from gastro-eso phageal reflux disease (GER). An esophagoscopy is assessing the degree of e sophagitis, which is treated with omeprazal. The meconium ileus of the newb orn is pathognomonic for the presence of cystic fibrosis. DIOS is present i n 35% of 1000 patient yea rs particularly in adolescents and adults with CF . Together with DIGS an acute appendicitis or an intusseption can be presen t. Since the daily dose of oral panceratic extracts has been limited, the o ccurence of fibrosing colonopathy has decreased. More often in the last few years a severe pancolitis was noticed in adult patients with CF due to Clo stridium difficile infection. Diarrhea, abdominal pain together with signs of inflammation lead to that severe, sometime life threatening disease. The ultrasonographic visualization of the colon shows enormous enlargement of the inflamed colon easely. Rare manifestation of CF in the GI-tract compris e malignant disease like adenocarcinoma,the infection with Giardia lamblia, the development of inflammatory bowel disease, e.g. Crohn's disease and th e occurence of celiac disease.